MedTrace Logo

Inflammatory Biomarkers for the Diagnosis of oPRES

NCT05433870 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 621

Last updated 2022-08-03

No results posted yet for this study

Summary

The purpose of this study is to explore the inflammatory biomarkers for the diagnosis of obstetric posterior reversible encephalopathy syndrome.

Conditions

  • Posterior Reversible Encephalopathy Syndrome
  • Inflammatory Biomarkers
  • Neutrophil-lymphocyte Ratio

Interventions

OTHER

Whether the PE or E patient combined with PRES

According to the Diagnostic criteria of PRES, all the patients grouped into two groups.

Sponsors & Collaborators

  • Dunjin Chen

    lead OTHER

Principal Investigators

  • Dunjin Chen · The Third Affiliated Hospital of Guangzhou Medical University

Eligibility

Min Age
16 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05433870 on ClinicalTrials.gov